Pharmaceutical firms witness sales edge up, but falling profits in Q3

After comprehensive price cuts of drugs by the government in April. local drug companies witnessed a sales stagnation during the third quarter of this year, but fell short of reaping more profits than the previous quarter, data showed Thursday.

Combined sales by 52 listed firms rose 1.1 percent in the third quarter from a year earlier, according to Yakup.com, a pharmaceutical information pro...